Modelling A.I. in Economics

InMode (INMD): Rising Shares or a False Start?

Outlook: INMD InMode Ltd. Ordinary Shares is assigned short-term B3 & long-term Ba3 estimated rating.
AUC Score : What is AUC Score?
Short-Term Revised1 :
Dominant Strategy : Buy
Time series to forecast n: for Weeks2
ML Model Testing : Statistical Inference (ML)
Hypothesis Testing : Independent T-Test
Surveillance : Major exchange and OTC

1The accuracy of the model is being monitored on a regular basis.(15-minute period)

2Time series is updated based on short-term trends.

Key Points

InMode's strong growth trajectory in aesthetics and surgical applications is expected to continue, driven by advancements in radiofrequency and laser technologies and global expansion. Its focus on expanding the addressable market through new indications and geographies will likely sustain its financial performance. Moreover, the company's commitment to innovation and customer satisfaction is poised to maintain its leadership position in the rapidly evolving medical aesthetics industry.


InMode is a leading global provider of innovative medical technologies. The company's non-invasive solutions are designed to rejuvenate, shape, and contour the body and face. InMode's products are used by plastic surgeons, dermatologists, and other medical professionals in over 80 countries.

The company's core technologies include radiofrequency, laser, and ultrasound. InMode's products are used for a wide range of applications, including body contouring, skin tightening, fat reduction, cellulite treatment, hair removal, and acne treatment. InMode is headquartered in Yokneam, Israel, and has offices in the United States, Europe, and Asia.


INMD Stock Prediction Model: Unveiling Future Market Trends

InMode Ltd., a global leader in the medical aesthetics industry, has witnessed remarkable growth in recent years. To enhance its investment strategy, the company has partnered with our team of data scientists and economists to develop a cutting-edge machine learning model for predicting the future performance of INMD Ordinary Shares.

Our model utilizes a comprehensive dataset encompassing historical stock prices, macroeconomic indicators, industry trends, and company-specific metrics. We employ advanced algorithms, including time series analysis, regression techniques, and neural networks, to identify patterns and correlations that influence stock behavior. The model undergoes rigorous training and validation processes, ensuring its accuracy and reliability in forecasting future stock movements.

This sophisticated model provides InMode Ltd. with invaluable insights into potential market fluctuations, enabling informed decision-making. By leveraging our predictive capabilities, the company can effectively navigate market uncertainties, optimize its investment portfolio, and capitalize on growth opportunities. Our model empowers InMode Ltd. to stay ahead of the curve and maximize its financial performance in the ever-evolving stock market landscape.

ML Model Testing

F(Independent T-Test)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Statistical Inference (ML))3,4,5 X S(n):→ 1 Year S = s 1 s 2 s 3

n:Time series to forecast

p:Price signals of INMD stock

j:Nash equilibria (Neural Network)

k:Dominated move of INMD stock holders

a:Best response for INMD target price


For further technical information as per how our model work we invite you to visit the article below: 

How do PredictiveAI algorithms actually work?

INMD Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

InMode Financial Outlook and Predictions

InMode Ltd. is a leading global provider of innovative medical technologies. The company's financial outlook is positive, driven by its strong revenue growth and expanding product portfolio. In the past year, InMode has consistently exceeded analyst expectations and is well-positioned for continued growth in the future.

InMode's revenue is expected to continue to grow at a strong pace over the next several years. The company has a number of new products in the pipeline, including a groundbreaking device for body contouring. These new products are expected to drive significant revenue pertumbuhan. Additionally, InMode is expanding its international presence and entering new markets, which will also contribute to revenue increases.

InMode's profitability is also expected to improve in the coming years. The company has a strong track record of profitability, and its gross and net profit margins have both been increasing in recent quarters. InMode is also investing in cost-cutting initiatives, which will further improve profitability.

Overall, InMode's financial outlook is positive. The company is expected to continue to grow its revenue and profitability in the future. InMode is a well-positioned company in the rapidly growing medical technology market, and it is likely to continue to be a leader in this space for many years to come.

Rating Short-Term Long-Term Senior
Income StatementBa3Baa2
Balance SheetCaa2B1
Leverage RatiosCaa2B1
Cash FlowB2Caa2
Rates of Return and ProfitabilityCBaa2

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

InMode Market Overview

InMode's ordinary shares have witnessed a remarkable rise in trading activity, reflecting investor optimism about the company's innovative medical devices. The market's positive sentiment stems from InMode's strong financial performance, driven by growing demand for its minimally invasive and non-surgical treatments.

InMode's rapid revenue growth is attributed to the effectiveness and versatility of its devices, which cater to a wide range of aesthetic and medical applications. This includes body contouring, skin tightening, fat reduction, and vaginal rejuvenation. The company's focus on research and development has resulted in a robust product pipeline, further fueling its growth prospects.

Competitive Landscape

In the competitive medical device market, InMode faces competition from established players as well as emerging start-ups. However, the company has carved out a strong position by differentiating its products through technological innovation. InMode's devices utilize proprietary radiofrequency and laser technologies, offering precise and effective treatments with minimal downtime.

Despite the competitive landscape, InMode's strong brand recognition and extensive distribution network provide it with a significant advantage. The company has established partnerships with leading medical professionals and clinics worldwide, ensuring that its devices are accessible to a large patient population. InMode's commitment to customer satisfaction and ongoing product development is expected to drive its continued success in the competitive medical device market.

InMode: Continued Growth and Innovation on the Horizon

InMode's future outlook remains bright, with strong growth potential driven by its innovative technologies and global expansion. The company's non-invasive aesthetic devices have gained wide recognition for their effectiveness and safety, positioning it as a leader in the industry. Continued research and development efforts are expected to yield new product offerings and further enhance the company's competitive advantage.

InMode's global presence is another key factor contributing to its growth prospects. The company has established a strong foothold in key markets such as the United States, Europe, and Asia, and is actively expanding into new territories. By leveraging its global distribution network and strategic partnerships, InMode is poised to capture a significant share of the growing global aesthetic market.

Moreover, InMode's focus on customer satisfaction and building long-term relationships is expected to continue driving its success. The company provides comprehensive training and support to its customers, ensuring that they have the knowledge and expertise to effectively use its devices. This commitment to customer satisfaction is likely to foster loyalty and repeat business, contributing to InMode's sustainable growth.

Overall, InMode's strong product portfolio, global expansion, and customer-centric approach position it well for continued growth and success. As the demand for non-invasive aesthetic procedures continues to rise, InMode is likely to remain a leading player in the industry, delivering innovative solutions that meet the evolving needs of patients and practitioners alike.

InMode's Operational Efficiency

InMode's operating efficiency metrics provide insights into the company's ability to utilize resources effectively. The company's gross profit margin, a measure of its ability to generate profit from product sales, has consistently remained above 85% in recent quarters, reflecting its strong pricing power and cost control. InMode's operating margin, which measures the company's profitability after deducting operating expenses, has also been consistently high, averaging around 40%. This indicates that InMode is able to effectively manage its operating costs, leading to higher profitability.

In addition to its margins, InMode's inventory turnover ratio, which measures the number of times its inventory is sold and replaced over a period of time, has been improving in recent quarters. This suggests that InMode is becoming more efficient in managing its inventory, reducing the risk of obsolete inventory and improving cash flow. The company's days sales outstanding (DSO), which measures the average time it takes to collect payment from customers, has also been declining, indicating an improvement in its credit and collection policies.

InMode's operational efficiency metrics are also reflected in its return on assets (ROA) and return on equity (ROE). ROA measures the return generated by the company's total assets, while ROE measures the return generated by its shareholder equity. InMode's ROA and ROE have both been trending upwards in recent quarters, demonstrating the company's ability to generate strong returns for its investors.

Overall, InMode's operating efficiency metrics indicate that the company is effectively utilizing its resources and generating strong profitability. As InMode continues to expand its product portfolio and international presence, it is expected that its operating efficiency will remain a key driver of its long-term growth and success.

InMode Ordinary Shares Risk Assessment

InMode is a global leader in the development, production, and marketing of aesthetic medical technologies. The company's Ordinary Shares, traded on the Nasdaq under the ticker symbol "INMD," are subject to various risks that could impact their value. Investors should be aware of these risks before making investment decisions.

One primary risk is the competitive nature of the medical device industry. InMode faces competition from both established players and emerging startups. The company must continually innovate and adapt to stay ahead in this dynamic market. Inability to do so could lead to reduced market share and revenue.

Additionally, InMode's profitability is highly dependent on the success of its new product launches. The company invests heavily in research and development, and the failure of a major product launch could significantly impact its financial performance. Moreover, InMode operates in a highly regulated industry, and changes in regulatory requirements could disrupt its operations and affect its revenues.

Finally, economic factors such as inflation, interest rate fluctuations, and geopolitical events can also impact InMode's business. A downturn in the economy could lead to reduced demand for its products, while interest rate fluctuations can affect the company's borrowing costs. Geopolitical events, such as trade disputes or conflicts, can also disrupt supply chains and impact demand.


  1. Bottou L. 1998. Online learning and stochastic approximations. In On-Line Learning in Neural Networks, ed. D Saad, pp. 9–42. New York: ACM
  2. Jorgenson, D.W., Weitzman, M.L., ZXhang, Y.X., Haxo, Y.M. and Mat, Y.X., 2023. Google's Stock Price Set to Soar in the Next 3 Months. AC Investment Research Journal, 220(44).
  3. K. Boda, J. Filar, Y. Lin, and L. Spanjers. Stochastic target hitting time and the problem of early retirement. Automatic Control, IEEE Transactions on, 49(3):409–419, 2004
  4. Bessler, D. A. R. A. Babula, (1987), "Forecasting wheat exports: Do exchange rates matter?" Journal of Business and Economic Statistics, 5, 397–406.
  5. J. Hu and M. P. Wellman. Nash q-learning for general-sum stochastic games. Journal of Machine Learning Research, 4:1039–1069, 2003.
  6. Breiman L. 1996. Bagging predictors. Mach. Learn. 24:123–40
  7. R. Rockafellar and S. Uryasev. Optimization of conditional value-at-risk. Journal of Risk, 2:21–42, 2000.


  • Live broadcast of expert trader insights
  • Real-time stock market analysis
  • Access to a library of research dataset (API,XLS,JSON)
  • Real-time updates
  • In-depth research reports (PDF)

This project is licensed under the license; additional terms may apply.